Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well exemestane before surgery works in treating
postmenopausal patients with newly diagnosed estrogen receptor positive stage II-III breast
cancer. Estrogen can cause the growth of breast cancer cells. Hormone therapy using
exemestane may fight breast cancer by blocking the use of estrogen by the tumor cells.